Mesenchymal stromal cells (MSCs), present in the stromal component of several tissues,
include multipotent stem cells, progenitors, and differentiated cells. MSCs have quickly …

Cancer remains a major cause of death globally. Given its relapsing and fatal features,
curing cancer seems to be something hardly possible for the majority of patients. In view of …

Purpose Although hematopoietic stem-cell transplantation is widely performed in children
with high-risk acute lymphoblastic leukemia (ALL), the influence of donor types is poorly …

Transplant-associated thrombotic microangiopathy (TA-TMA) is a severe complication of
hematopoietic stem cell transplantation (HSCT). A single-center prospective screening study …

Acute graft-versus-host disease (aGvHD) continues to impact morbidity and mortality after
allogeneic stem cell transplantation (allo-SCT). First-line therapy for aGvHD still remains the …

Children with Down syndrome (DS) have a significantly increased risk of childhood
leukemia, in particular acute megakaryoblastic leukemia (AMKL) and acute lymphoblastic …

It is well acknowledged that allogeneic hematopoietic stem cell transplantation (allo-HSCT)
is an effective treatment for numerous malignant blood diseases, which has also been …

The correlation existing between gut microbiota diversity and survival after allogeneic
hematopoietic stem cell transplantation (allo-HSCT) has so far been studied in adults …

Purpose Children and young adults with hypodiploid B-lymphoblastic leukemia (B-ALL) fare
poorly and hematopoietic stem-cell transplantation (HSCT) is often pursued in first complete …

Minimal residual disease (MRD) during early chemotherapy is a powerful predictor of
relapse in acute lymphoblastic leukaemia (ALL) and is used in children to determine …